Stay updated on BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer

Sign up to get notified when there's something new on the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page.
Latest website image capture
Clouds background image

Latest updates to the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T03:52:48.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-25T04:30:01.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-18T03:29:21.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision was updated from v3.7.0 to v3.7.1, while the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T06:54:24.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the expected study content and navigation. This blocks access to the study record and related details.
    Difference
    23%
    Check dated 2026-09-20T02:42:02.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.6) replacing the previous v3.6.5, indicating a new build of the page with no obvious changes to study details.
    Difference
    0.0%
    Check dated 2026-08-29T23:50:05.000Z thumbnail image

Stay in the know with updates to BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer

Enter your email address, and we'll notify you when there's something new on the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page.